Literature DB >> 16049241

A hydroxyapatite-coated total knee replacement: prospective analysis of 1000 patients.

M J Cross1, E N Parish.   

Abstract

We prospectively reviewed 1000 consecutive patients who underwent a cementless, hydroxyapatite-coated, stemless, total knee replacement over a period of nine years. Regular post-operative clinical follow-up was performed using the Knee Society score. The mean pre-operative score was 96, improving to 182 and 180 at five and ten years, respectively. To date, there have been seven (0.5%) cases which required revision, primarily for septic loosening (four cases), with low rates of other post-operative complications. The cumulative survival at ten years with revision as the end-point, was 99.14% (95% confidence interval 92.5 to 99.8). These results support the use of hydroxyapatite in a cementless total knee replacement since it can give reliable fixation with an excellent clinical and functional outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049241     DOI: 10.1302/0301-620X.87B8.15772

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  11 in total

1.  Optimisation of the enamelling of an apatite-mullite glass-ceramic coating on Ti6Al4V.

Authors:  Kevin P O'Flynn; Kenneth T Stanton
Journal:  J Mater Sci Mater Med       Date:  2011-07-20       Impact factor: 3.896

2.  No difference in joint awareness after mobile- and fixed-bearing total knee arthroplasty: 3-year follow-up of a randomized controlled trial.

Authors:  M G M Schotanus; P Pilot; R Vos; N P Kort
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-02-09

3.  Does computer-assisted surgery influence survivorship of cementless total knee arthroplasty in patients with primary osteoarthritis? A 10-year follow-up study.

Authors:  Hervé Ouanezar; Florent Franck; Alexandre Jacquel; Vincent Pibarot; Julien Wegrzyn
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-07       Impact factor: 4.342

Review 4.  Highlighting the advantages and benefits of cementless total knee arthroplasty (Review).

Authors:  Bogdan Uivaraseanu; Cosmin Mihai Vesa; Delia Mirela Tit; Octavian Maghiar; Teodor Andrei Maghiar; Calin Hozan; Aurelia Cristina Nechifor; Tapan Behl; Felicia Liana Andronie-Cioara; Jenel Marian Patrascu; Simona Bungau
Journal:  Exp Ther Med       Date:  2021-11-18       Impact factor: 2.447

5.  Good long-term results following cementless TKA with a titanium plasma coating.

Authors:  Theodore Bouras; Vasileios Bitas; Peter Fennema; Panagiotis Korovessis
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-09-03       Impact factor: 4.342

6.  The beneficial effect of hydroxyapatite lasts: a randomized radiostereometric trial comparing hydroxyapatite-coated, uncoated, and cemented tibial components for up to 16 years.

Authors:  Bart G Pijls; Edward R Valstar; Bart L Kaptein; Marta Fiocco; Rob G H H Nelissen
Journal:  Acta Orthop       Date:  2012-02-13       Impact factor: 3.717

7.  Cemented or cementless total knee arthroplasty? - Comparative results of 200 cases at a minimum follow-up of 11 years.

Authors:  Jean-Louis Prudhon; Régis Verdier
Journal:  SICOT J       Date:  2017-12-12

8.  No differences in cost-effectiveness and short-term functional outcomes between cemented and uncemented total knee arthroplasty.

Authors:  R Rassir; P A Nolte; J C T van der Lugt; R G H H Nelissen; I N Sierevelt; W C Verra
Journal:  BMC Musculoskelet Disord       Date:  2020-07-09       Impact factor: 2.362

9.  Design and rationale of the ATtune Knee Outcome Study (ATKOS): multicenter prospective evaluation of a novel uncemented rotating platform knee system.

Authors:  Rachid Rassir; Inger N Sierevelt; Marjolein Schager; Peter A Nolte
Journal:  BMC Musculoskelet Disord       Date:  2021-07-15       Impact factor: 2.362

10.  Total knee arthroplasty using NexGen LPS-flex® improves clinical outcomes without early loosening: minimum 6-year follow-up results.

Authors:  Yoon Sang Jeon; Joong Sup Shin; Jae Ho Jung; Myung Ku Kim
Journal:  J Orthop Surg Res       Date:  2016-07-21       Impact factor: 2.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.